Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Ridinger elected at board meeting
April 3, 2012
By: Tim Wright
Editor-in-Chief, Contract Pharma
Richard Ridinger has been named chief executive officer of Lonza at a board meeting on April 2. Mr. Ridinger will take over the role on May 1. Chairman Rolf Soiron held the job on an interim basis since the end of January, when Stefan Borgas was fired. “Richard Ridinger could be a person who grew up with Lonza,” said Mr. Soiron. “He is a chemical engineer who knows our industries, customers and products. With Richard Ridinger, we were not only able to attract a man of action and team player, but also a winning personality.” Mr. Ridinger has held numerous leadership functions at Henkel for 14 years and Cognis for 11 years. Most recently, he was responsible for Care Chemicals, the largest sector at Cognis, with approximately 3,000 employees. During his tenure, sales increased by 60% to $2.3 billion over six years, repositioning the business in the market. Mr. Ridinger’s has experience in process development, production management, and product and marketing management of different product areas, leading global business units, and co-responsibility for leading a worldwide group of the specialty chemicals. In his new role, Mr. Ridinger has been “mandated with strengthening Lonza’s market position in relevant markets, strengthening competitive capabilities, and productivity improvement in critical areas,” according to a Lonza statement. This will include the “Visp Challenge,” which is expected to contribute more than $110 million over three years; Mr. Ridinger will also oversee a review of group-wide structures. At the same board meeting, Marc Funk, who currently serves as group general counsel and board secretary, was elected to Lonza’s Management Committee. Mr. Funk joined Lonza in January 2009. He was previously associate general counsel at Merck Serono.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !